OBJECTIVE: Prevalence of non-alcoholic fatty liver disease is rising in the Western world and reaches up to 90% in patients undergoing bariatric surgery. Fibroscan(®) as a non-invasive tool for liver stiffness measurement (LSM) has several limitations in morbidly obese patients. Only few data exist about the technical feasibility and accuracy of LSM in these patients. We aimed to analyse the feasibility of LSM by Fibroscan(®) in bariatric patients. MATERIALS AND METHODS: In morbidly obese patients, LSM was performed using XL probe. Measurements were termed reliable if 10 successful measurements with a success rate ≥60% and an interquartile range/median (IQR/M) <0.3 were obtained, unreliable if 10 successful measurements were obtained but the IQR/M was >0.3, and they were termed failed if they were neither reliable nor unreliable. RESULTS: A total of 149 patients were included (87 with liver biopsies); mean BMI was 51.6 ± 8.5 kg/m(2). In 41% LSM using XL-probe was reliable, in 22% unreliable and in 37% failed. Failed LSM was significantly more frequent in patients with higher BMI compared to reliable and unreliable measurements (p < 0.05). In patients with failed measurement, sonographic paramedian and intercostal distances were significantly higher compared to reliable measurements. All three patients with F4 fibrosis could successfully be differentiated by LSM from patients without fibrosis. CONCLUSIONS: LSM with XL probe is feasible in almost two-thirds of morbidly obese patients with a BMI ≥50 kg/m(2). Reliable prediction of advanced fibrosis appears to be possible even if formal criteria of successful measurements are not met.
OBJECTIVE: Prevalence of non-alcoholic fatty liver disease is rising in the Western world and reaches up to 90% in patients undergoing bariatric surgery. Fibroscan(®) as a non-invasive tool for liver stiffness measurement (LSM) has several limitations in morbidly obesepatients. Only few data exist about the technical feasibility and accuracy of LSM in these patients. We aimed to analyse the feasibility of LSM by Fibroscan(®) in bariatric patients. MATERIALS AND METHODS: In morbidly obesepatients, LSM was performed using XL probe. Measurements were termed reliable if 10 successful measurements with a success rate ≥60% and an interquartile range/median (IQR/M) <0.3 were obtained, unreliable if 10 successful measurements were obtained but the IQR/M was >0.3, and they were termed failed if they were neither reliable nor unreliable. RESULTS: A total of 149 patients were included (87 with liver biopsies); mean BMI was 51.6 ± 8.5 kg/m(2). In 41% LSM using XL-probe was reliable, in 22% unreliable and in 37% failed. Failed LSM was significantly more frequent in patients with higher BMI compared to reliable and unreliable measurements (p < 0.05). In patients with failed measurement, sonographic paramedian and intercostal distances were significantly higher compared to reliable measurements. All three patients with F4 fibrosis could successfully be differentiated by LSM from patients without fibrosis. CONCLUSIONS: LSM with XL probe is feasible in almost two-thirds of morbidly obesepatients with a BMI ≥50 kg/m(2). Reliable prediction of advanced fibrosis appears to be possible even if formal criteria of successful measurements are not met.
Authors: Magdalena Eilenberg; Petra Munda; Judith Stift; Felix B Langer; Gerhard Prager; Michael Trauner; Katharina Staufer Journal: Hepatobiliary Surg Nutr Date: 2021-10 Impact factor: 7.293
Authors: PreyaJanubhai Patel; Fabrina Hossain; Leigh Ula Horsfall; Xuan Banh; Kelly Lee Hayward; Suzanne Williams; Tracey Johnson; Anne Bernard; Nigel Neil Brown; Guy Lampe; Lyndall Buck; Nivene Saad; Anthony William Russell; Patricia Casarolli Valery; Katharine Margaret Irvine; Andrew Donald Clouston; Katherine Anne Stuart; William Rosenberg; Elizabeth Ellen Powell Journal: Hepatol Commun Date: 2018-08-06
Authors: Philippe Garteiser; Laurent Castera; Muriel Coupaye; Sabrina Doblas; Daniela Calabrese; Marco Dioguardi Burgio; Séverine Ledoux; Pierre Bedossa; Marina Esposito-Farèse; Simon Msika; Bernard E Van Beers; Pauline Jouët Journal: JHEP Rep Date: 2021-09-30
Authors: Ahmad Hassan Ali; Alhareth Al Juboori; Gregory F Petroski; Alberto A Diaz-Arias; Majid M Syed-Abdul; Andrew A Wheeler; Rama R Ganga; James B Pitt; Nicole M Spencer; Ghassan M Hammoud; R Scott Rector; Elizabeth J Parks; Jamal A Ibdah Journal: J Clin Med Date: 2022-02-23 Impact factor: 4.964
Authors: Ramon Rawache Lima; José Huygens Parente Garcia; Marina Seixas Studart; Fernando Siqueira Pinheiro; João Odilo Gonçalves Pinto; Leonardo Adolpho Sales; Lucas Marrocos Soares; Priscilla de Almeida Santos Journal: Arq Bras Cir Dig Date: 2022-08-26
Authors: Andreas Drolz; Stefan Wolter; Malte H Wehmeyer; Felix Piecha; Thomas Horvatits; Julian Schulze Zur Wiesch; Ansgar W Lohse; Oliver Mann; Johannes Kluwe Journal: Int J Obes (Lond) Date: 2021-06-24 Impact factor: 5.095